You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

12 search results for: remission

Asthma <b>Remission</b>: Moving Beyond Control
interactivity

Asthma Remission: Moving Beyond Control

Pulmonology
Learn about the proposed framework for clinical remission in patients with asthma.
View more
On-Treatment Clinical <b>Remission</b> in Asthma Patients Case Tool
interactivity

On-Treatment Clinical Remission in Asthma Patients Case Tool

Pulmonology
Review a severe asthma patient case to learn more about assessing asthma control and on-treatment clinical remission.
View more
Clinical <b>Remission</b> as a Goal in Asthma Clinical Practice
expert video

Clinical Remission as a Goal in Asthma Clinical Practice

Pulmonology
Profs. Alberto Papi and Ian Pavord discuss clinical remission as a goal in asthma clinical practice beyond symptom control.
View more
ADVENT On Air | <b>Remission</b> in CRSwNP
Podcast

ADVENT On Air | Remission in CRSwNP

Rhinology
Prof. Peter Hellings and Dr. Stella Lee discuss the concept of remission for patients with chronic rhinosinusitis with nasal polyps.
View more
IRS-ISIAN 2024 | Emerging Expert Definitions of <b>Remission</b> in CRSwNP
expert video

IRS-ISIAN 2024 | Emerging Expert Definitions of Remission in CRSwNP

Rhinology
Prof. Peter Hellings highlights the EPOS/EUFOREA 2024 definition of remission and calls for an elevation of treatment goals in CRSwNP.
View more
ADVENT On Air | The Road Ahead: Achieving <b>Remission</b> for ​Patients With Asthma
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease <b>Remission</b>
expert video

IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Rhinology
Prof. Peter Hellings and Prof. Eugenio De Corso discuss viewpoints on the emerging definitions of disease remission in CRSwNP.
View more
ADVENT On Air | What Is the Future Outlook for <b>Remission</b> in Pediatric Severe Asthma?
Podcast

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?

Pulmonology
Join Drs. Len Bacharier and Sharon Dell as they highlight the natural course of pediatric asthma progression over time.
View more
CSU is Associated With a High Burden and Impact on Quality of Life
expert video

CSU is Associated With a High Burden and Impact on Quality of Life

Dermatology
Dr. Casale discusses delays in diagnosing CSU, the impact of severe itch on daily life and mental health, and the challenges in achieving remission.
View more
IRS-ISIAN 2024 | Guideline Definitions of Control in CRSwNP
expert video

IRS-ISIAN 2024 | Guideline Definitions of Control in CRSwNP

Rhinology
Prof. Peter Hellings explores the concept of disease control in CRSwNP.
View more
ADVENT On Air - Dermatology
Podcast

ADVENT On Air | Expert Discussions in Dermatology

Dermatology
Listen to the latest updates in type 2 inflammatory science and associated skin diseases, brought to you by leading dermatology experts in the field. ADVENT On Air podcasts feature scientific conversations that explore new research into the pathophysiology, clinical features, and disease burden for a range of dermatological diseases linked to type 2 inflammation, including atopic dermatitis (AD) and prurigo nodularis (PN). Hear new insights revealed through expert-led conversations below or in your preferred podcast app.

View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region